| Thomas S Kollodge, | |
|
25 Johnson Ave, Dillon, MT 59725-3323 | |
| (406) 683-2020 | |
| Not Available |
| Full Name | Thomas S Kollodge |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 9 Years |
| Location | 25 Johnson Ave, Dillon, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689055931 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 3395 (Wisconsin) | Secondary |
| 152W00000X | Optometrist | 3435 (Minnesota) | Secondary |
| 152W00000X | Optometrist | OPT-OPT-LIC-4926 (Montana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gundersen Clinic Ltd | 9638082779 | 359 |
News Archive
Selecta Biosciences, Inc., a biopharmaceutical company developing synthetic nanoparticle vaccines, today announced that it has raised $15 million in a Series C financing round. OrbiMed Advisors LLC led the round, with participation from existing investors Polaris Venture Partners, Flagship Ventures, NanoDimension and Leukon Investments. The Series C financing brings the total capital raised by Selecta over the past 15 months to more than $30 million.
In other Medicaid news, the Obama administration has dispatched experts to go into the field to help budget-strapped states find ways to save money on the health insurance program for the poor.
Growth hormone is used to treat children's growth disorders and has been used by some sports men and women to promote muscle growth and regeneration. This is because it coordinates skeletal muscle development, nutrient uptake, and nutrient utilization. It is not clear, however, which of these effects are direct and which are indirectly mediated via growth hormone induction of the protein IGF-1.
A blood test may shed new light on Fragile X syndrome related disorders in women, according to a new study published in the March 25, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology. Fragile X is the most common inherited form of intellectual disability and the most frequent genetic cause of autism.
› Verified 4 days ago
| Provider Name | Gundersen Clinic Ltd |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1851343115 PECOS PAC ID: 9638082779 Enrollment ID: O20031106000139 |
News Archive
Selecta Biosciences, Inc., a biopharmaceutical company developing synthetic nanoparticle vaccines, today announced that it has raised $15 million in a Series C financing round. OrbiMed Advisors LLC led the round, with participation from existing investors Polaris Venture Partners, Flagship Ventures, NanoDimension and Leukon Investments. The Series C financing brings the total capital raised by Selecta over the past 15 months to more than $30 million.
In other Medicaid news, the Obama administration has dispatched experts to go into the field to help budget-strapped states find ways to save money on the health insurance program for the poor.
Growth hormone is used to treat children's growth disorders and has been used by some sports men and women to promote muscle growth and regeneration. This is because it coordinates skeletal muscle development, nutrient uptake, and nutrient utilization. It is not clear, however, which of these effects are direct and which are indirectly mediated via growth hormone induction of the protein IGF-1.
A blood test may shed new light on Fragile X syndrome related disorders in women, according to a new study published in the March 25, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology. Fragile X is the most common inherited form of intellectual disability and the most frequent genetic cause of autism.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas S Kollodge, 25 Johnson Ave, Dillon, MT 59725-3323 Ph: (406) 683-2020 | Thomas S Kollodge, 25 Johnson Ave, Dillon, MT 59725-3323 Ph: (406) 683-2020 |
News Archive
Selecta Biosciences, Inc., a biopharmaceutical company developing synthetic nanoparticle vaccines, today announced that it has raised $15 million in a Series C financing round. OrbiMed Advisors LLC led the round, with participation from existing investors Polaris Venture Partners, Flagship Ventures, NanoDimension and Leukon Investments. The Series C financing brings the total capital raised by Selecta over the past 15 months to more than $30 million.
In other Medicaid news, the Obama administration has dispatched experts to go into the field to help budget-strapped states find ways to save money on the health insurance program for the poor.
Growth hormone is used to treat children's growth disorders and has been used by some sports men and women to promote muscle growth and regeneration. This is because it coordinates skeletal muscle development, nutrient uptake, and nutrient utilization. It is not clear, however, which of these effects are direct and which are indirectly mediated via growth hormone induction of the protein IGF-1.
A blood test may shed new light on Fragile X syndrome related disorders in women, according to a new study published in the March 25, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology. Fragile X is the most common inherited form of intellectual disability and the most frequent genetic cause of autism.
› Verified 4 days ago
Precision Eyecare & Optical Optometrist Medicare: Medicare Enrolled Practice Location: 25 Johnson Ave, Dillon, MT 59725 Phone: 406-683-2020 Fax: 406-683-6409 | |
Bradley P Kepp Od Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 25 Johnson Ave, Dillon, MT 59725 Phone: 406-683-2020 Fax: 406-683-6409 | |
Dr. Zachary Mclean Oswald, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 25 Johnson Ave, Dillon, MT 59725 Phone: 406-683-2020 Fax: 406-683-6409 | |
Dr. John Everett Creger, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 233 E Glendale St, Dillon, MT 59725 Phone: 406-683-2611 | |
Dr. Douglas D Creger, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 233 E Glendale St, Dillon, MT 59725 Phone: 406-683-2611 Fax: 406-683-2676 | |
Douglas D Creger Od Optometrist Medicare: Medicare Enrolled Practice Location: 233 E Glendale St, Dillon, MT 59725 Phone: 406-683-2611 Fax: 406-683-2676 |